Page last updated: 2024-10-23

buformin and Cell Transformation, Neoplastic

buformin has been researched along with Cell Transformation, Neoplastic in 1 studies

Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research Excerpts

ExcerptRelevanceReference
"Metformin is a widely prescribed drug for the treatment of type II diabetes."1.42Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat. ( Echeverria, D; Jiang, W; McGinley, JN; Thompson, HJ; Thompson, MD; Zhu, Z, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhu, Z1
Jiang, W1
Thompson, MD1
Echeverria, D1
McGinley, JN1
Thompson, HJ1

Other Studies

1 other study available for buformin and Cell Transformation, Neoplastic

ArticleYear
Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.
    Cancer prevention research (Philadelphia, Pa.), 2015, Volume: 8, Issue:6

    Topics: Animals; Apoptosis; Blotting, Western; Buformin; Carcinogens; Cell Proliferation; Cell Transformatio

2015